Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Depreciation & Amortization (CF): 2023-2024

Historic Depreciation & Amortization (CF) for Camp4 Therapeutics (CAMP) over the last 2 years, with Dec 2024 value amounting to $1.7 million.

  • Camp4 Therapeutics' Depreciation & Amortization (CF) fell 0.48% to $416,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 1.63%. This contributed to the annual value of $1.7 million for FY2024, which is 1.07% up from last year.
  • As of FY2024, Camp4 Therapeutics' Depreciation & Amortization (CF) stood at $1.7 million, which was up 1.07% from $1.7 million recorded in FY2023.
  • In the past 5 years, Camp4 Therapeutics' Depreciation & Amortization (CF) ranged from a high of $1.7 million in FY2024 and a low of $1.7 million during FY2023.
  • Moreover, its 2-year median value for Depreciation & Amortization (CF) was $1.7 million (2023), whereas its average is $1.7 million.
  • Data for Camp4 Therapeutics' Depreciation & Amortization (CF) shows a peak YoY increased of 1.07% (in 2024) over the last 5 years.
  • Over the past 2 years, Camp4 Therapeutics' Depreciation & Amortization (CF) (Yearly) stood at $1.7 million in 2023, then grew by 1.07% to $1.7 million in 2024.